Thursday, November 19, 2026 | 07:30 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Emcure Pharmaceuticals Ltd News

Adani Ports, Bosch, Divi's Labs, Marico, Welspun Living hit record highs

Indian Hotels Company, PVR Inox and Zydus Lifesciences from the BSE 500 index have hit their respective 52-week highs.

Adani Ports, Bosch, Divi's Labs, Marico, Welspun Living hit record highs
Updated On : 04 Nov 2026 | 12:33 PM IST

Emcure Pharma surges 10%, stock hits new high on strong outlook

Analysts at Jefferies remain positive on Emcure Pharma's near- to mid-term outlook, supported by multiple growth drivers and operating-leverage benefits.

Emcure Pharma surges 10%, stock hits new high on strong outlook
Updated On : 04 Nov 2026 | 10:08 AM IST

Emcure Pharma Q2FY27 net profit rises 34% to ₹325.5 crore, revenue up 24%

Emcure Pharmaceuticals reports 24.2 per cent revenue growth in Q2FY27, led by strong international sales, while domestic business expands 12 per cent and net profit rises 33.7 per cent

Emcure Pharma Q2FY27 net profit rises 34% to ₹325.5 crore, revenue up 24%
Updated On : 03 Nov 2026 | 5:06 PM IST

Emcure Pharma up over 3% as board approves merger of two subsidiaries

Emcure Pharmaceuticals will merge its wholly owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, with itself under the proposed scheme.

Emcure Pharma up over 3% as board approves merger of two subsidiaries
Updated On : 12 Oct 2026 | 11:51 AM IST

International business to remain key driver for Emcure Pharma in FY27

Emcure expects overseas markets to drive growth in FY27 through product approvals, differentiated offerings and capacity expansion, while domestic business is seen improving

International business to remain key driver for Emcure Pharma in FY27
Updated On : 06 Aug 2026 | 7:17 PM IST

Adani Ports, Radico, KFin among 6 top stock ideas for Aug by Motilal Oswal

Motilal Oswal Wealth Management Research Desk recommends 2 stocks each from the large-cap, mid-cap and small-cap segment for August 2026.

Adani Ports, Radico, KFin among 6 top stock ideas for Aug by Motilal Oswal
Updated On : 03 Aug 2026 | 7:46 AM IST

Emcure Pharma up 3% after CDSCO approves semaglutide for MASH treatment

The approval makes the innovator molecule from Novo Nordisk the first and only GLP-1 receptor agonist approved in India for the treatment of the disease.

Emcure Pharma up 3% after CDSCO approves semaglutide for MASH treatment
Updated On : 21 Jul 2026 | 2:28 PM IST

Emcure broadens Poviztra's use for MASH after CDSCO nod for semaglutide

The drugmaker will market Poviztra for treating MASH after CDSCO approved the new indication for innovator semaglutide, expanding the medicine's approved uses in India

Emcure broadens Poviztra's use for MASH after CDSCO nod for semaglutide
Updated On : 20 Jul 2026 | 8:38 PM IST

Emcure Pharma makes Gennova wholly owned, names Samit Mehta CEO

Restructuring positions biotech arm to focus on biologics and biosimilar

Emcure Pharma makes Gennova wholly owned, names Samit Mehta CEO
Updated On : 13 Jul 2026 | 5:44 PM IST